← Back to Search

Herbal Supplement

Milk Thistle for Gambling Addiction

Phase 2
Waitlist Available
Led By Jon E Grant, JD, MD, MPH
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once every two weeks for the 8 weeks of the study
Awards & highlights

Study Summary

This trial will test if silymarin, a substance derived from milk thistle, is an effective and safe treatment for gambling disorder.

Eligible Conditions
  • Gambling Addiction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once every two weeks for the 8 weeks of the study
This trial's timeline: 3 weeks for screening, Varies for treatment, and once every two weeks for the 8 weeks of the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Yale Brown Obsessive Compulsive Scale Modified for Pathological Gambling (PG-YBOCS)
Secondary outcome measures
Clinical Global Impression-Improvement and Severity scales (CGI)
Gambling Symptom Assessment Scale (G-SAS)
Hamilton Anxiety Rating Scale (HAM-A)
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Milk ThistleActive Control1 Intervention
Capsule form, 150mg BID to 300mg BID
Group II: PlaceboPlacebo Group1 Intervention
Matched dosage of milk thistle daily.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
819,734 Total Patients Enrolled
Jon E Grant, JD, MD, MPHPrincipal InvestigatorUniversity of Chicago
7 Previous Clinical Trials
834 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025